New oral anticoagulants: prevention of VTE in phase III studies in total joint replacement surgery and the hospitalized medically-ill patients.
Galanis, Taki
New oral anticoagulants: prevention of VTE in phase III studies in total joint replacement surgery and the hospitalized medically-ill patients. [electronic resource] - Journal of thrombosis and thrombolysis Aug 2013 - 141-8 p. digital
Publication Type: Journal Article; Review
1573-742X
10.1007/s11239-013-0955-3 doi
Anticoagulants--adverse effects
Arthroplasty, Replacement
Clinical Trials, Phase III as Topic
Factor Xa Inhibitors
Female
Hospitalization
Humans
Male
Monitoring, Physiologic--methods
Thrombin--antagonists & inhibitors
United States
Venous Thromboembolism--epidemiology
New oral anticoagulants: prevention of VTE in phase III studies in total joint replacement surgery and the hospitalized medically-ill patients. [electronic resource] - Journal of thrombosis and thrombolysis Aug 2013 - 141-8 p. digital
Publication Type: Journal Article; Review
1573-742X
10.1007/s11239-013-0955-3 doi
Anticoagulants--adverse effects
Arthroplasty, Replacement
Clinical Trials, Phase III as Topic
Factor Xa Inhibitors
Female
Hospitalization
Humans
Male
Monitoring, Physiologic--methods
Thrombin--antagonists & inhibitors
United States
Venous Thromboembolism--epidemiology